| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9918 |
| Human Intestinal Absorption | HIA+ | 0.9932 |
| Caco-2 Permeability | Caco2+ | 0.7891 |
| P-glycoprotein Substrate | Substrate | 0.8498 |
| P-glycoprotein Inhibitor | Inhibitor | 0.8737 |
| Non-inhibitor | 0.8207 |
| Renal Organic Cation Transporter | Inhibitor | 0.5297 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4104 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8427 |
| CYP450 2D6 Substrate | Substrate | 0.6886 |
| CYP450 3A4 Substrate | Substrate | 0.8119 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7900 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8903 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.6162 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8443 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7301 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7398 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8930 |
| Non-inhibitor | 0.8581 |
| AMES Toxicity | Non AMES toxic | 0.7457 |
| Carcinogens | Non-carcinogens | 0.9386 |
| Fish Toxicity | High FHMT | 0.9614 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9832 |
| Honey Bee Toxicity | High HBT | 0.5964 |
| Biodegradation | Not ready biodegradable | 0.9292 |
| Acute Oral Toxicity | III | 0.5715 |
| Carcinogenicity (Three-class) | Non-required | 0.5982 |